학술논문
A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations
Document Type
Article
Author
Ninomiya, Takashi; Ishikawa, Nobuhisa; Kozuki, Toshiyuki; Kuyama, Shoichi; Inoue, Koji; Yokoyama, Toshihide; Kanaji, Nobuhiro; Yasugi, Masayuki; Shibayama, Takuo; Aoe, Keisuke; Ochi, Nobuaki; Fujitaka, Kazunori; Kodani, Masahiro; Ueda, Yutaka; Watanabe, Kazuhiko; Bessho, Akihiro; Sugimoto, Keisuke; Oze, Isao; Hotta, Katsuyuki; Kiura, Katsuyuki
Source
In Lung Cancer October 2023 184
Subject
Language
ISSN
0169-5002